SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BULLOCK DONALD R

(Last)

(First)

(Middle)

C/O SAGENT PHARMACEUTICALS, INC.

1901 NORTH ROSELLE ROAD, SUITE 700

(Street)

SCHAUMBURG

60195

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/27/2016

3. Issuer Name and Ticker or Trading Symbol
Sagent Pharmaceuticals, Inc. [ SGNT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive V.P. Sales

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,663	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option to Buy	08/10/2007	08/10/2017	Common Stock	607	$2.51	D
Stock Option to Buy	06/01/2009	08/15/2018	Common Stock	6,870	$4.23	D
Stock Option to Buy	12/11/2010	12/11/2019	Common Stock	5,103	$4.31	D
Stock Option to Buy	11/22/2011	12/02/2020	Common Stock	5,103	$11.6	D
Stock Option to Buy	02/29/2012	05/06/2021	Common Stock	1,000	$21.96	D
Stock Option to Buy	02/22/2013	02/22/2022	Common Stock	1,950	$22.04	D
Stock Option to Buy	⁽¹⁾	02/21/2023	Common Stock	9,969	$16.45	D
Stock Option to Buy	⁽²⁾	02/18/2024	Common Stock	3,546	$20.16	D
Stock Option to Buy	⁽³⁾	02/25/2025	Common Stock	4,788	$27.15	D
Stock Option to Buy	⁽⁴⁾	02/22/2026	Common Stock	6,522	$14.61	D

Explanation of Responses:

1. Stock option is presently exercisable with respect to 7,476 shares of common stock and will become exercisable with respect to an additional 2,493 shares of common stock on February 21, 2017.

2. Stock option is presently exercisable with respect to 1,773 shares of common stock and will become exercisable with respect to an additional 886 shares of common stock on February 18, 2017 and an additional 887 shares of common stock on February 18, 2018.

3. Stock option is presently exercisable with respect to 1,197 shares of common stock and will become exercisable with respect to an additional 1,197 shares of common stock on February 25, 2017, an additional 1,197 shares of common stock on February 25, 2018 and an additional 1,197 shares of common stock on February 25, 2019.

4. Stock option will become exercisable with respect to 1,630 shares of common stock on February 22, 2017, an additional 1,630 shares of common stock on February 22, 2018, an additional 1,631 shares of common stock on February 22, 2019, and an additional 1,631 shares of common stock on February 22, 2020.

Remarks:

	/s/ Donald R. Bullock	06/27/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.